this is a basic presentation about the corona virus, made on the basis of secondary data collected from various websites regarding the curative, preventive and treatment for the corona virus.
After the intravenous transplantation of MSCs, a significant population of cells accumulates in the lung, which they alongside immunomodulatory effect could protect alveolar epithelial cells, reclaim the pulmonary microenvironment, prevent pulmonary fibrosis, and cure lung dysfunction. The fact that the transplantation of MSCs improved the outcome of COVID-2019 patients may be due to regulating inflammatory response and promoting tissue repair and regeneration. This is a preliminary report of our study in Iran.
After the intravenous transplantation of MSCs, a significant population of cells accumulates in the lung, which they alongside immunomodulatory effect could protect alveolar epithelial cells, reclaim the pulmonary microenvironment, prevent pulmonary fibrosis, and cure lung dysfunction. The fact that the transplantation of MSCs improved the outcome of COVID-2019 patients may be due to regulating inflammatory response and promoting tissue repair and regeneration. This is a preliminary report of our study in Iran.
Innovative Solutions to Combat Spread & Management of Covid-19Sidharth Mehta
As we know, COVID-19 is spreading worldwide and its only treatment is just Prevention from it. However there is no specific Drug/Medicine till available for this disease. In this report I try to demonstrate some Innovative Solutions to Combat Spread & Management of Covid-19. Hope you guys like this report..Please Let me know some suggestions if you have in the comment section below. #STAYHOME #STAYSAFE
Bedside to Bench: How Clinical Imaging of Patients with COVID-19 is Informing...Scintica Instrumentation
In this webinar presented by Scintica Instrumentation, we took a look at both clinical and preclinical imaging of COVID-19. Starting with a review of current literature surrounding clinical imaging and post-mortem histological autopsy studies of patients with COVID-19, this webinar examined how these studies can inform prospective preclinical investigations using novel imaging tools to better understand COVID-19 pathophysiology
We all know how COVID is affecting all our lives, we see people getting themselves tested for the infection, we merely know what is the procedure and what are the tests done.
We all know the noble Coronavirus replicates some of its functioning and symptoms to that of the SARS virus. However, the SARS-CoV-2 virus has an e-gene which makes it envelope around the viral shell making the enzyme RNA dependent RNA Polymerase. It takes almost 24-48 hrs to get the results if the test confirms the person is COVID positive or negative.
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian PerspectiveLallu Joseph
This presentation is about the preparation of Indian Hospitals towards managing patients during the COVID 19 Pandemic. This is based on experience shared by hospitals for the benefit of other hospitals to prepare themselves. How to set up the Hospital Incident Command System, components of managing the pandemic like infection control, Engineering Controls, Patient flow and Triaging, Supply chain management including PPE, Clinical management, Manpower management and shifts, Training.
Coronavirus: medical management in a developed country that is china versus a...Vedica Sethi
The systemic review has focused on to compare the available treatment options applied by China and India to manage the current pandemic situation, in their respective countries.
Everything we need to know about COVID-19PrincessExtra
These slides is uploaded for information and as a partial requirement of Philippine Women's University in Master of Nursing (MAN); Subject: Nursing Practicum
Innovative Solutions to Combat Spread & Management of Covid-19Sidharth Mehta
As we know, COVID-19 is spreading worldwide and its only treatment is just Prevention from it. However there is no specific Drug/Medicine till available for this disease. In this report I try to demonstrate some Innovative Solutions to Combat Spread & Management of Covid-19. Hope you guys like this report..Please Let me know some suggestions if you have in the comment section below. #STAYHOME #STAYSAFE
Bedside to Bench: How Clinical Imaging of Patients with COVID-19 is Informing...Scintica Instrumentation
In this webinar presented by Scintica Instrumentation, we took a look at both clinical and preclinical imaging of COVID-19. Starting with a review of current literature surrounding clinical imaging and post-mortem histological autopsy studies of patients with COVID-19, this webinar examined how these studies can inform prospective preclinical investigations using novel imaging tools to better understand COVID-19 pathophysiology
We all know how COVID is affecting all our lives, we see people getting themselves tested for the infection, we merely know what is the procedure and what are the tests done.
We all know the noble Coronavirus replicates some of its functioning and symptoms to that of the SARS virus. However, the SARS-CoV-2 virus has an e-gene which makes it envelope around the viral shell making the enzyme RNA dependent RNA Polymerase. It takes almost 24-48 hrs to get the results if the test confirms the person is COVID positive or negative.
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian PerspectiveLallu Joseph
This presentation is about the preparation of Indian Hospitals towards managing patients during the COVID 19 Pandemic. This is based on experience shared by hospitals for the benefit of other hospitals to prepare themselves. How to set up the Hospital Incident Command System, components of managing the pandemic like infection control, Engineering Controls, Patient flow and Triaging, Supply chain management including PPE, Clinical management, Manpower management and shifts, Training.
Coronavirus: medical management in a developed country that is china versus a...Vedica Sethi
The systemic review has focused on to compare the available treatment options applied by China and India to manage the current pandemic situation, in their respective countries.
Everything we need to know about COVID-19PrincessExtra
These slides is uploaded for information and as a partial requirement of Philippine Women's University in Master of Nursing (MAN); Subject: Nursing Practicum
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
The severity and mortality of COVID 19 cases has been associated with the Three category such as vaccination status, severity of disease and outcome. Objective presently study was aimed to assess the severity and mortality among covid 19 patients. Methods Using simple lottery random method 100 samples were selected. From these 100 patients, 50 patients were randomly assigned to case group and 50 patients in control group after informed consents of relative obtained. Patients in the case group who being died after got COVID 19 whereas 50 patients in the control group participated who were survive after got infected from COVID 19 patients. Result It has three categories such as a Vaccination status For the vaccination status we have seen 59 patients were not vaccinated and 41 patients was vaccinated out of 100. b Incidence There were 41 patients were vaccinated whereas 59 patients were not vaccinated. c Severity In the case of mortality we selected 50 patients who were died from the Corona and I got to know that out of 50 patients there were 12 24 patients were vaccinated whereas 38 76 patients were non vaccinated. Although for the 50 control survival group total 29 58 patients were vaccinated and 21 42 patients was not vaccinated all graph start. Conclusion we have find out that those people who got vaccinated were less infected and mortality rate very low. Prof. (Dr) Binod Kumar Singh | Dr. Saroj Kumar | Ms. Anuradha Sharma "To Assess the Severity and Mortality among Covid-19 Patients after Having Vaccinated: A Retrospective Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd45065.pdf Paper URL: https://www.ijtsrd.com/other-scientific-research-area/other/45065/to-assess-the-severity-and-mortality-among-covid19-patients-after-having-vaccinated-a-retrospective-study/prof-dr-binod-kumar-singh
Diagnosis of the novel coronavirus disease 2019 (covid 19)Makrani Shaharukh
COVID-19 is a disease caused by a new strain of coronavirus. ‘CO’ stands for corona, ‘VI’ for virus, and ‘D’ for disease. Formerly, this disease was referred to as ‘2019 novel coronavirus’ or ‘2019-nCoV.’The COVID-19 virus is a new virus linked to the same family of viruses as Severe Acute Respiratory Syndrome and some types of common cold. Diagnostic testing is possibly the only efficient way to monitor the spread of the SARS-CoV-2 in time and space.The WHO has appealed for global mass testing.
Quinine for covid 19 a case presentation for low and middle income economiesBisi Bright
LiveWell Initiative LW, a self funded nonprofit social enterprise which thrives on innovation. (www.livewellng.org) has recommended the use of repurposed Quinine for Moderate to Severe COVID-19 by compiling three (3) sets of STUDY PROTOCOLS in response to the COVID-19 RESPONSE with a goal to arriving at a practical and affordable solution to the pandemic. The Protocols underwent debates and Hypothesis testing among Physicians, Researchers and Virologitsts. They are still undergoing random Physician – Patient Trials at the discretion of Prescribing Clinicians and Clinical Researchers, they are as recommended in a compilation of recent findings by LiveWell Initiative LWI on COVID-19. LiveWell Initiative LWI, a nonprofit organisation, takes no liability for damage from the use of the above suggested STUDY PROTOCOLS FOR COVID-19 RESPONSE. It is a Study Protocol designed to ‘evolve’ as a Solution to COVID-19 Response.
The Protocols strongly suggest the use of Quinine for COVID-19 Treatment in moderate to advanced disease, recommending intravenous infusion of Quinine for critical care in COVID-19. The sample size is small and further studies are recommended but the result is significant. The preliminary results were positive, and posted online even as the concurrent study continues.
In conclusion, Quinine is impactful with positive outcomes for severe or advanced COVID-19 especially after the Cytokine Storm, with 5-7 days total recovery after the onset of the cytokine storm.Due to small preliminary sample size with 100% positive outcome, a full study shoud be commissioned to establish and quantify the impact of Quinine on thousands in a population. This will help to prevent further morbidity in COVID-19 and the cytokine storm will be greatly overcome.
The novel coronavirus disease 2019 (covid 19)overviewMakrani Shaharukh
COVID-19 is a disease caused by a new strain of coronavirus. ‘CO’ stands for corona, ‘VI’ for virus, and ‘D’ for disease. Formerly, this disease was referred to as ‘2019 novel coronavirus’ or ‘2019-nCoV.’The COVID-19 virus is a new virus linked to the same family of viruses as Severe Acute Respiratory Syndrome and some types of common cold. The Coronavirus (COVID-19) was first reported in Wuhan, Hubei, China in December 2019, the outbreak was later recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, Avoid close contact with anyone.
Attention Deficit Disorder (ADD) and Attention Deficit Hyperactive Disorder (...MdMontazAli
Attention Deficit Disorder (ADD) and Attention Deficit Hyperactive Disorder (ADHD) are two of the most common neurological disorders diagnosed in children and teens.
ADD is characterized by the person's brain not being able to correctly regulate attention. This makes it hard to control impulses or complete a task that is perceived as routine or boring, while able to focus on a task found stimulating, such as a video game.
ADD is a developmental disorder that is present in up to 7.8 percent of children and about 4 percent of adults.
Coronavirus Disease-19 and Reinfections: A Review of Casesasclepiuspdfs
Since first surfacing in Wuhan, China, in December 2019, the novel coronavirus disease-2019 (COVID-19) has led to a global pandemic with confirmed cases and death bells tolling in the millions with new cases still emerging daily. Despite sharing genetic similarities to the severe acute respiratory syndrome (SARS) virus, the specific viral proteins found on the novel SARS coronavirus 2 and its structure seems to make this strain much more elusive and destructive. Based on peer-reviewed cases, there seems to be an increase in patient reinfection, but due to current testing and treatment limitations, it is yet to be determined if the new trend of reinfection is due to a persistent COVID-19 infection that involves a latent period, a recurrent infection due to the same strain of COVID-19, or a mutated strain of COVID-19. The purpose of this study is to discuss the recent reports of the development of reinfection in previously confirmed COVID-19 cases in an attempt to gain a further understanding of the mechanisms of virulence, the effects on the human immune system, and how current testing and treatment modalities are faring. While the virus seems to have a penchant for patients with existing comorbidities, newer data indicate that everyone may be susceptible to possible infection and that not all patients will present with typical respiratory symptoms, making it imperative to examine established cases of reinfection in an attempt to further help with developing drugs for treatment, vaccines, and protocols for prevention.
Corona virus was first identified as a cause of the common cold in 1960. Until 2002, the virus was considered a relatively simple, nonfatal virus.Over the last three decades there have been three attacks of three different coronaviruses, SARS-CoV, MERS CoV and the recent one 2019 novel coronavirus (2019-nCoV).
Corona viruses are a group of viruses that infect human & birds. Human corona virus is enveloped, single stranded, positive sense RNA virus. Only seven strain of corona virus are infect man, in which four are circulating in human population.
Novel corona virus 2019 (nCoV2019) is a newly identified human corona virus that has 94% similarity of SARS corona virus. The outbreak of this virus was reported to on 31 December, 2019. The WHO declared the outbreak as a public health emergence of international concern on 23 January. prevention is better than cure.
No vaccine is available.
There is no vaccine available to prevent this infection,
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Artificial Intelligence to Optimize Cardiovascular Therapy
Covid 19
1. BASICS ABOUT THE COVID-19
PREVENTIONS, TREATMENTS AND CURE
Krushna.v
2. Covid-19
Corona virus disease-2019
It was previously called as the 2019 novel corona virus,
since it’s a new strain that has not been previously
identified in humans
The SARS and the CoronaVirus are genetically related
but are two different diseases.
3. The virus causing the disease is the severe acute
respiratory syndrome coronavirus 2
(SARS-CoV-2)
The outbreak was first found to be in wuhan, china, in
december 2019
It’s a pandemic disease.
7. Various Treatments against the
Corona virus
plasma from recovered
COVID-19 patients to
treat others
Nano materials to
combat the corona
virus
Stem cell therapy to
treat and possibly cure
the corona infections
Herd Immunity
8. plasma from recovered COVID-19
patients to treat others
Doctors and researchers believe that the Convalescent plasma therapy could be effective until
the vaccine is discovered.
9. Areas that uses the plasma
therapy
five critically ill patients with
Covid-19 in shenzen, china all of
whom improved after receiving
convalescent plasma
transfusions
Texas hospitals that plan to try
the treatment include
Methodist Hospital Stone Oak
in San Antonio, University of
Texas Southwestern Medical
Center in Dallas and the Bayor
college of medicine in houston
10. Facts about the plasma
therapy
The Food and Drug
Administration has yet to
approve the treatment
but is allowing initial
clinical trials. Because
those trials are limited,
doctors nationally can
also request the FDA’s
permission to use the
treatment for severe
COVID-19 cases.
Since then, hospital
systems around the
nation have registered
through the Mayo Clinic
to start treating patients
with convalescent plasma
This is not the first time
physicians have used
plasma to combat
infectious diseases before
a vaccine is developed.
The technique was used
to treat hemorrhagic
fever in 1979 and the
spanish influenza
12. China develops nano
materials that can
combat the corona virus
It is said that the nano
materials are smaller
than the human hair’s
diameter and can’t be
viewed by a naked eye.
They say that these
nano materials can bind
with the corona virus
especially the RNA’s and
would make them
inactive
13. Stem cell Therapy to possibly
cure the Corona Virus
Chinese doctors are having some initial success using stem
cells to treat — and possibly cure — coronavirus infections.
Dr. DongchengWu, who runs a stem cell lab inWuhan, China
– the epicenter of theCOVID-19 outbreak – says he has
successfully treated nine critically ill patients hospitalized
with coronavirus pneumonia.
BHI is currently recruiting 48 coronavirus patients in China
for a placebo-controlled study of MSC injections.
In studies on mice, researchers found that MSC cells
migrated to the lungs, where they significantly reduced
inflammation and repaired damaged tissue.
14. Herd Immunity
Considering an entire
population as an
Individual and
Immunizing them
against a particular
infectious Disease